Shore Capital and Baden Hill advised on an equity fundraising to raise up to £12 million for Oxford BioDynamics plc

2 minute read
11 October 2022

Key contact(s):

Our Corporate team has advised Shore Capital (Nomad and joint broker) and Baden Hill (joint broker) on a Placing to raise £9.1 million and an Open Offer to raise a further £2.9 million for AIM-listed company, Oxford BioDynamics plc.

Oxford BioDynamics plc is a biotechnology company developing targeted clinical diagnostic tests for immune health based on the EpiSwitch® 3D genomics platform. The funds will help facilitate working capital to accelerate the commercialisation of its vital 'EpiSwitch®' product line. EpiSwitch® CiRT is a first-of-its-kind precision medicine test that predicts a cancer patient's likely response to Immune Checkpoint Inhibitors (ICIs).

The Gowling WLG team was led by corporate partner, Jeff Elway, assisted by associate, Abby Parkin.

Commenting, Jeff said:

"We are delighted to be involved in another equity fundraising in the Life Sciences sector, with Oxford BioDynamics' flagship product being such a vital service in the ongoing fight against cancer. The fundraise is at a significant premium to the company's recent share price, demonstrating investors' continued belief in the value of the company and its products."

Gowling WLG's global corporate practice offer a complete range of services, from domestic and cross border M&A, private equity and joint ventures through to complex reorganisations, providing industry-leading legal support and sector expertise to deliver on clients' objectives.

NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.

Related   Life Sciences, Corporate